Inhibition of the cystic fibrosis transmembrane conductance regulator by ATP-sensitive K+ channel regulators.
Sheppard
D N
DN
Howard Hughes Medical Institute, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242, USA.
Welsh
M J
MJ
D000255:Adenosine Triphosphate / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D003550:Cystic Fibrosis / Q000503:physiopathology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000502:physiology*; D006706:Homeostasis; D006801:Humans; D015221:Potassium Channels / Q000502:physiology*; D017433:Protein Structure, Secondary; D013453:Sulfonylurea Compounds / Q000494:pharmacology
C505032:CFTR protein, human; D015221:Potassium Channels; D013453:Sulfonylurea Compounds; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D000255:Adenosine Triphosphate